Anti-tumour necrosis factor therapy in ankylosing spondylitis. A need for guidelines.
Kassimos
D G
DG
Garyfallos
A
A
Delamere
J
J
Whallett
A
A
Kitas
G D
GD
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D006801:Humans; D017410:Practice Guidelines as Topic; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha